Abstract
Most bioactive natural products currently known are synthesized by members of the Actinomycetales order. The development of genetic engineering provides novel genetic tools for the modification of known antibiotics and other bioactive compounds to generate derivatives with improved therapeutic properties. This new technology, named combinatorial biosynthesis, is able of introducing structural modifications in bioactive compounds not easily accessible by chemical means. Furthermore, progress in genome sequencing in this group of microorganisms shows that actinomycetes have a greater potential of synthesizing bioactive compounds than was anticipated. Each genome sequenced shows the presence of 18–37 gene clusters potentially directing the biosynthesis of bioactive compounds that have not been previously identified. Novel strategies are being developed to activate these cryptic or silent gene clusters in these microorganisms, allowing the identification of novel potentially bioactive compounds. This chapter will revise the state of the art in this field of research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baig I, Pérez M, Braña AF et al (2008) Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity. J Nat Prod 71:199–207
Baltz RH (2010) Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J Ind Microbiol Biotechnol 37:759–772
Baquero F, Coque TM, de la Cruz F (2011) Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother 55:3649–3660
Bérdy J (2012) Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot 65:385–395
Blodgett JA, Oh DC, Cao S et al (2010) Common biosynthetic origins for polycyclic tetramate macrolactams from phylogenetically diverse bacteria. Proc Natl Acad Sci USA 107:11692–11697
Brady SF, Simmons L, Kim JH et al (2009) Metagenomic approaches to natural products from free-living and symbiotic organisms. Nat Prod Rep 26:1488–1503
Brakhage AA, Schroeckh V (2011) Fungal secondary metabolites—strategies to activate silent gene clusters. Fungal Genet Biol 48:15–22
Brautaset T, Bruheim P, Sletta H et al (2002) Hexaene derivatives of nystatin produced as a result of an induced rearrangement within the nysC polyketide synthase gene in S. noursei ATCC 11455. Chem Biol 9:367–373
Butler MS, Cooper MA (2011) Antibiotics in the clinical pipeline in 2011. J Antibiot 64:413–425
Carlet J, Jarlier V, Harbarth S et al (2012) Ready for a world without antibiotics? The pensières antibiotic resistance call to action. Antimicrob Resist Infect Control 1:11
Carlson JC, Li S, Gunatilleke SS et al (2011) Tirandamycin biosynthesis is mediated by co-dependent oxidative enzymes. Nat Chem 3:628–633
Chen LF, Kaye D (2011) Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides. Med Clin North Am 95:819–842
Claesen J, Bibb M (2010) Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of post translationally modified peptides. Proc Natl Acad Sci USA 107:16297–16302
Craney A, Ozimok C, Pimentel-Elardo SM et al (2012) Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem Biol 19:1020–1027
Cunha BA (2006) New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin North Am 90:1089–1107
Daum M, Herrmann S, Wilkinson B et al (2009) Genes and enzymes involved in bacterial isoprenoid biosynthesis. Curr Opin Chem Biol 13:180–188
Davies J (2011) How to discover new antibiotics: harvesting the parvome. Curr Opin Chem Biol 15:5–10
Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433
D’Costa VM, King CE, Kalan L et al (2011) Antibiotic resistance is ancient. Nature 477:457–461
Demain AL, Sanchez S (2009) Microbial drug discovery: 80 years of progress. J Antibiot 62:5–16
Dhillon N, Hale RS, Cortés J et al (1989) Molecular characterization of a gene from Saccharopolyspora erythraea (Streptomyces erythraeus) which is involved in erythromycin biosynthesis. Mol Microbiol 3:1405–1414
Doekel S, Coëffet-Le Gal MF, Gu JQ et al (2008) Non-ribosomal peptide synthetase module fusions to produce derivatives of daptomycin in Streptomyces roseosporus. Microbiology 154:2872–2880
Donadio S, Monciardini P, Sosio M (2007) Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat Prod Rep 24:1073–1109
Donadio S, Maffioli S, Monciardini P et al (2010) Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot 63:423–430
Eppelmann K, Stachelhaus T, Marahiel MA (2002) Exploitation of the selectivity-conferring code of nonribosomal peptide synthetases for the rational design of novel peptide antibiotics. Biochemistry 41:9718–9726
Fedorova ND, Moktali V, Medema MH (2012) Bioinformatics approaches and software for detection of secondary metabolic gene clusters. Methods Mol Biol 944:23–45
Fernandes P (2006) Antibacterial discovery and development—the failure of success? Nat Biotechnol 24:1497–1503
Fernández E, Weissbach U, Sánchez Reillo C et al (1998) Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin. J Bacteriol 180:4929–4937
Gao B, Gupta RS (2012) Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. Microbiol Mol Biol Rev 76:66–112
Ghosh P, Bagchi MC (2011) Anti-tubercular drug designing by structure based screening of combinatorial libraries. J Mol Model 17:1607–1620
Gómez C, Horna DH, Olano C et al (2011) Amino acid precursor supply in the biosynthesis of the RNA polymerase inhibitor streptolydigin by Streptomyces lydicus. J Bacteriol 193:4214–4223
Gómez C, Olano C, Méndez C et al (2012a) Three pathway-specific regulators control streptolydigin biosynthesis in Streptomyces lydicus. Microbiology 158:2504–2514
Gómez C, Olano C, Palomino-Schätzlein M et al (2012b) Novel compounds produced by Streptomyces lydicus NRRL 2433 engineered mutants altered in the biosynthesis of streptolydigin. J Antibiot 65:341–348
Gottelt M, Kol S, Gomez-Escribano JP et al (2010) Deletion of a regulatory gene within the cpk gene cluster reveals novel antibacterial activity in Streptomyces coelicolor A3(2). Microbiology 156:2343–2353
Gross H, Loper JE (2009) Genomics of secondary metabolite production by Pseudomonas spp. Nat Prod Rep 26:1408–1446
Han AR, Park JW, Lee MK et al (2011) Development of a Streptomyces venezuelae-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates. Appl Environ Microbiol 77:4912–4923
Harvey CJ, Puglisi JD, Pande VS et al (2012) Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket. J Am Chem Soc 134:12259–12265
Heide L, Gust B, Anderle C et al (2008) Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics. Curr Top Med Chem 8:667–679
Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Edit 48:4688–4716
Horna DH, Gómez C, Olano C et al (2011) Biosynthesis of the RNA polymerase inhibitor streptolydigin in Streptomyces lydicus: tailoring modification of 3-methyl-aspartate. J Bacteriol 193:2647–2651
Hu GP, Yuan J, Sun L et al (2011) Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 9:514–525
Hutchings KM, Tran TP, Ellsworth EL et al (2008) Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones. Bioorg Med Chem Lett 18:5087–5090
Imhoff JF, Labes A, Wiese J (2011) Bio-mining the microbial treasures of the ocean: new natural products. Biotechnol Adv 29:468–482
Jeya M, Moon HJ, Lee KM et al (2011) Glycopeptide antibiotics and their novel semi-synthetic derivatives. Curr Pharm Biotechnol 12:1194–1204
Kalaitzis JA, Lauro FM, Neilan BA (2009) Mining cyanobacterial genomes for genes encoding complex biosynthetic pathways. Nat Prod Rep 26:1447–1465
Kelly WL, Pan L, Li C (2009) Thiostrepton biosynthesis: prototype for a new family of bacteriocins. J Am Chem Soc 131:4327–4334
Koglin A, Walsh CT (2009) Structural insights into nonribosomal peptide enzymatic assembly lines. Nat Prod Rep 26:987–1000
Kwon SJ, Mora-Pale M, Lee MY et al (2012) Expanding nature’s small molecule diversity via in vitro biosynthetic pathway engineering. Curr Opin Chem Biol 16:186–195
Lasken RS (2012) Genomic sequencing of uncultured microorganisms from single cells. Nat Rev Microbiol 10:631–640
Laureti L, Song L, Huang S et al (2011) Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci USA 108:6258–6263
Lazos O, Tosin M, Slusarczyk AL et al (2010) Biosynthesis of the putative siderophore erythrochelin requires unprecedented crosstalk between separate nonribosomal peptide gene clusters. Chem Biol 17:160–173
Lin X, Hopson R, Cane DE (2006) Genome mining in Streptomyces coelicolor: molecular cloning and characterization of a new sesquiterpene synthase. J Am Chem Soc 128:6022–6023
Liu WT, Kersten RD, Yang YL et al (2011) Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporus. J Am Chem Soc 133:18010–18913
Loman NJ, Constantinidou C, Chan JZ et al (2012) High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10:599–606
Lombó F, Gibson M, Greenwell L et al (2004) Engineering biosynthetic pathways for deoxysugars: branched-chain sugar pathways and derivatives from the antitumor tetracenomycin. Chem Biol 11:1709–1718
Lombó F, Abdelfattah MS, Braña AF et al (2009) Elucidation of oxygenation steps during oviedomycin biosynthesis and generation of derivatives with increased antitumor activity. ChemBioChem 10:296–303
Long TE (2003) Recent progress toward the clinical development of new anti-MRSA antibiotics. IDrugs 6:351–359
Luzhetskyy A, Méndez C, Salas JA et al (2008) Glycosyltransferases, important tools for drug design. Curr Top Med Chem 8:680–709
Marsden AF, Wilkinson B, Cortés J et al (1998) Engineering broader specificity into an antibiotic-producing polyketide synthase. Science 279:199–202
McDaniel R, Thamchaipenet A, Gustafsson C et al (1999) Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel “unnatural” natural products. Proc Natl Acad Sci USA 96:1846–1851
Méndez C, Luzhetskyy A, Bechthold A et al (2008) Deoxysugars in bioactive natural products: development of novel derivatives by altering the sugar pattern. Curr Top Med Chem 8:710–724
Minovski N, Perdih A, Solmajer T (2012) Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment. J Mol Model 18:1735–1753
Mo X, Wang Z, Wang B et al (2011) Cloning and characterization of the biosynthetic gene cluster of the bacterial RNA polymerase inhibitor tirandamycin from marine-derived Streptomyces sp. SCSIO1666. Biochem Biophys Res Commun 406:341–347
Moore JM, Bradshaw E, Seipke RF et al (2012) Use and discovery of chemical elicitors that stimulate biosynthetic gene clusters in streptomyces bacteria. Methods Enzymol 517:367–385
Mootz HD, Kessler N, Linne U et al (2002) Decreasing the ring size of a cyclic nonribosomal peptide antibiotic by in-frame module deletion in the biosynthetic genes. J Am Chem Soc 124:10980–10981
Moss SJ, Carletti I, Olano C et al (2006) Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues. Chem Commun 22:2341–2343
Mutak S (2007) Azalides from azithromycin to new azalide derivatives. J Antibiot 60:85–122
Nakano C, Ootsuka T, Takayama K et al (2011) Characterization of the Rv3378c gene product, a new diterpene synthase for producing tuberculosinol and (13R, S)-isotuberculosinol (nosyberkol), from the Mycobacterium tuberculosis H37Rv genome. Biosci Biotechnol Biochem 75:75–81
Nett M, Ikeda H, Moore BS (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26(11):1362–1384
Nguyen KT, He X, Alexander DC et al (2010) Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties. Antimicrob Agents Chemother 54:1404–1413
Olano C, Wilkinson B, Sánchez C et al (2004a) Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tü4055: cluster analysis and assignment of functions. Chem Biol 11:87–97
Olano C, Moss SJ, Braña AF et al (2004b) Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tü4055: insights into nitrile formation. Mol Microbiol 52:1745–1756
Olano C, Lombó F, Méndez C et al (2008a) Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab Eng 10:281–292
Olano C, Abdelfattah MS, Gullón S et al (2008b) Glycosylated derivatives of steffimycin: insights into the role of the sugar moieties for the biological activity. ChemBioChem 9:624–633
Olano C, Gómez C, Pérez M et al (2009) Deciphering biosynthesis of the RNA polymerase inhibitor streptolydigin and generation of glycosylated derivatives. Chem Biol 16:1031–1044
Olano C, Méndez C, Salas JA (2010) Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis. Nat Prod Rep 27:571–616
Olano C, Méndez C, Salas JA (2011) Gene clusters for bioactive natural products in actinomycetes and their use in combinatorial biosynthesis. In: Dyson P (ed) Streptomyces molecular biology and biotechnology, 1st edn. Caiser Academic Press, Norfolk, pp 195–232
Onaka H, Mori Y, Igarashi Y et al (2011) Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species. Appl Environ Microbiol 77:400–406
Ou X, Zhang B, Zhang L et al (2009) Characterization of rrdA, a TetR family protein gene involved in the regulation of secondary metabolism in Streptomyces coelicolor. Appl Environ Microbiol 75:2158–2165
Palaniappan N, Ayers S, Gupta S et al (2006) Production of hygromycin A analogs in Streptomyces hygroscopicus NRRL2388 through identification and manipulation of the biosynthetic gene cluster. Chem Biol 13:753–764
Park JW, Park SR, Nepal KK et al (2011) Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation. Nat Chem Biol 7:843–852
Pawlik K, Kotowska M, Chater KF et al (2007) A cryptic Type I polyketide synthase (cpk) gene cluster in Streptomyces coelicolor A3(2). Arch Microbiol 187:87–99
Pérez M, Lombó F, Zhu L et al (2005) Combining sugar biosynthesis genes for the generation of L- and D-amicetose and formation of two novel antitumor tetracenomycins. Chem Commun 12:1604–1606
Pérez M, Lombó F, Baig I et al (2006) Combinatorial biosynthesis of antitumor deoxysugar pathways in Streptomyces griseus: Reconstitution of “unnatural natural gene clusters” for the biosynthesis of four 2,6-D-dideoxyhexoses. Appl Environ Microbiol 72:6644–6652
Pérez M, Baig I, Braña AF et al (2008) Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis. ChemBioChem 9:2295–2304
Phillips JW, Goetz MA, Smith SK et al (2011) Discovery of kibdelomycin, a potent new class of bacterial Type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Chem Biol 18:955–965
Ramos JL, Martínez-Bueno M, Molina-Henares AJ et al (2005) The TetR family of transcriptional repressors. Microbiol Mol Biol Rev 69:326–356
Rateb ME, Houssen WE, Harrison WT et al (2011) Diverse metabolic profiles of a Streptomyces strain isolated from a hyper-arid environment. J Nat Prod 74:1965–1971
Rawlings BJ (2001) Type I polyketide biosynthesis in bacteria (Part A—erythromycin biosynthesis). Nat Prod Rep 18:190–227
Read AF, Day T, Huijben S (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci USA 108:10871–10877
Reeves CD, Murli S, Ashley GW et al (2001) Alteration of the substrate specificity of a modular polyketide synthase acyltransferase domain through site-specific mutations. Biochemistry 40:15464–15470
Remsing LL, Garcia-Bernardo J, Gonzalez A et al (2002) Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway. J Am Chem Soc 124:1606–1614
Robbel L, Knappe TA, Linne U et al (2010) Erythrochelin-a hydroxamate-type siderophore predicted from the genome of Saccharopolyspora erythraea. FEBS J 277:663–676
Rodríguez L, Oelkers C, Aguirrezabalaga I et al (2000) Generation of hybrid elloramycin analogs by combinatorial biosynthesis using genes from anthracycline-type and macrolide biosynthetic pathways. J Mol Microbiol Biotechnol 2:271–276
Rodríguez L, Rodríguez D, Olano C et al (2001) Functional analysis of OleY L-oleandrosyl 3-O-methyltransferase of the oleandomycin biosynthetic pathway in Streptomyces antibioticus. J Bacteriol 183:5358–5363
Romero D, Traxler MF, López D et al (2011) Antibiotics as signal molecules. Chem Rev 111:5492–5505
Sakoulas G, Nam SJ, Loesgen S et al (2012) Novel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureus. PLoS ONE 7:e29439
Salas JA, Méndez C (2007) Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol 15:219–232
Salas AP, Zhu L, Sánchez C et al (2005) Deciphering the late steps in the biosynthesis of the anti-tumour indolocarbazole staurosporine: sugar donor substrate flexibility of the StaG glycosyltransferase. Mol Microbiol 58:17–27
Sánchez C, Zhu L, Braña AF et al (2005) Combinatorial biosynthesis of antitumor indolocarbazole compounds. Proc Natl Acad Sci USA 102:461–466
Sánchez C, Salas AP, Braña AF et al (2009) Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles. Chem Commun 21:4118–4120
Seipke RF, Kaltenpoth M, Hutchings MI (2012) Streptomyces as symbionts: an emerging and widespread theme? FEMS Microbiol Rev 36:862–876
Seyedsayamdost MR, Traxler MF, Clardy J et al (2012) Old meets new: using interspecies interactions to detect secondary metabolite production in actinomycetes. Methods Enzymol 517:89–109
Singh BK, Macdonald CA (2010) Drug discovery from uncultivable microorganisms. Drug Discov Today 15:792–799
Singh SB, Young K, Miesel L (2011) Screening strategies for discovery of antibacterial natural products. Expert Rev Anti Infect Ther 9:589–613
Song L, Barona-Gomez F, Corre C et al (2006) Type III polyketide synthase β-ketoacyl-ACP starter unit and ethylmalonyl-CoA extender unit selectivity discovered by Streptomyces coelicolor genome mining. J Am Chem Soc 128:14754–14755
Sun Y, Zhou X, Liu J et al (2002) ‘Streptomyces nanchangensis’, a producer of the insecticidal polyether antibiotic nanchangmycin and the antiparasitic macrolide meilingmycin, contains multiple polyketide gene clusters. Microbiology 148:361–371
Takamatsu S, Lin X, Nara A et al (2011) Characterization of a silent sesquiterpenoid biosynthetic pathway in Streptomyces avermitilis controlling epi-isozizaene albaflavenone biosynthesis and isolation of a new oxidized epi-isozizaene metabolite. Microb Biotechnol 4:184–191
Tang L, McDaniel R (2001) Construction of desosamine containing polyketide libraries using a glycosyltransferase with broad substrate specificity. Chem Biol 8:547–555
Thapa LP, Oh TJ, Liou K et al (2008) Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003. J Appl Microbiol 105:300–308
Torrieri R, Oliveira FS, Oliveira G et al (2012) Automatic assignment of prokaryotic genes to functional categories using literature profiling. PLoS ONE 7:e47436
Toscano L, Fioriello G, Spagnoli R et al (1983) New fluorinated erythromycins obtained by mutasynthesis. J Antibiot 36:1439–1450
Walsh CT, Chen H, Keating TA et al (2001) Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Curr Opin Chem Biol 5:525–534
Wang J, Soisson SM, Young K et al (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441:358–361
Wang G, Hosaka T, Ochi K (2008) Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl Environ Microbiol 74:2834–2840
Ward SL, Desai RP, Hu Z et al (2007) Precursor-directed biosynthesis of 6-deoxyerythronolide B analogues is improved by removal of the initial catalytic sites of the polyketide synthase. J Ind Microbiol Biotechnol 34:9–15
Weber JM, Schoner B, Losick R (1989) Identification of a gene required for the terminal step in erythromycin A biosynthesis in Saccharopolyspora erythraea (Streptomyces erythreus). Gene 75:235–241
Wenzel SC, Muller R (2009) The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat Prod Rep 26:1385–1407
Winter JM, Tang Y (2012) Synthetic biological approaches to natural product biosynthesis. Curr Opin Biotechnol 23:736–743
Winter JM, Behnken S, Hertweck C (2011) Genomics-inspired discovery of natural products. Curr Opin Chem Biol 15:22–31
Wood DE, Lin H, Levy-Moonshine A et al (2012) Thousands of missed genes found in bacterial genomes and their analysis with COMBREX. Biol Direct 7:37
World Health Organization (2011) The top ten causes of death. Fact sheet N°310. http://www.who.int Updated Jun 2011
Xue Q, Ashley G, Hutchinson CR et al (1999) A multiplasmid approach to preparing large libraries of polyketides. Proc Natl Acad Sci USA 96:11740–11745
Zerikly M, Challis GL (2009) Strategies for the discovery of new natural products by genome mining. ChemBioChem 10:625–633
Ziemert N, Jensen PR (2012) Phylogenetic approaches to natural product structure prediction Methods Enzymol 517:161–182
Acknowledgments
Research at the authors’ laboratory has been supported by grants from Spanish Ministry of Science and Innovation (BIO2008-00269 to C. Méndez; BIO2009-07643 to J. A. Salas), Red Temática de Investigación Cooperativa de Centros de Cáncer (Ministry of Health, ISCIII-RETIC RD06/0020/0026) to J. A. Salas, and Obra Social Cajastur to C. Olano.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olano, C., Méndez, C., Salas, J.A. (2014). Strategies for the Design and Discovery of Novel Antibiotics using Genetic Engineering and Genome Mining. In: Villa, T., Veiga-Crespo, P. (eds) Antimicrobial Compounds. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40444-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-40444-3_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40443-6
Online ISBN: 978-3-642-40444-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)